Free tool
FAERS Monitor: Stimate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020355 or its brand name (Stimate, Desmopressin Acetate). Reports on generic versions are filed under their own applications.
Reports
2,425
Serious
1,645
68% of reports
Hospitalization
890
Death reported
150
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- hyponatraemia237
- headache177
- drug ineffective176
- nausea125
- fatigue102
- off label use94
- vomiting94
- dizziness79
- flushing67
- pain66
- diarrhoea61
- epistaxis61
- condition aggravated59
- recalled product administered57
- malaise56
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 20 |
| 2005 | 21 |
| 2006 | 34 |
| 2007 | 34 |
| 2008 | 113 |
| 2009 | 96 |
| 2010 | 95 |
| 2011 | 90 |
| 2012 | 103 |
| 2013 | 42 |
| 2014 | 84 |
| 2015 | 104 |
| 2016 | 190 |
| 2017 | 164 |
| 2018 | 141 |
| 2019 | 131 |
| 2020 | 144 |
| 2021 | 140 |
| 2022 | 127 |
| 2023 | 128 |
| 2024 | 173 |
| 2025 | 154 |
| 2026 | 97 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,734 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| recalled product administeredSignal | 57 | 52.1 | 40.3 | 2,793 |
| hyponatraemiaSignal | 237 | 36.7 | 32.5 | 8,170 |
| epistaxisSignal | 61 | 7.1 | 5.5 | 313 |
| flushingSignal | 67 | 5.7 | 4.5 | 257 |
| headacheSignal | 177 | 2.4 | 2.1 | 155 |
| vomiting | 94 | 1.7 | 1.4 | 29 |
| condition aggravated | 59 | 1.7 | 1.3 | 16 |
| dizziness | 79 | 1.4 | 1.1 | 8 |
| nausea | 125 | 1.4 | 1.2 | 13 |
| drug ineffective | 176 | 1.2 | 1.0 | 4 |
| fatigue | 102 | 1.1 | 0.9 | 2 |
| malaise | 56 | 1.1 | 0.9 | 0 |
| pain | 66 | 0.9 | 0.7 | 0 |
| off label use | 94 | 0.9 | 0.8 | 0 |
| diarrhoea | 61 | 0.8 | 0.6 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.